ArticleThe Journal of clinical investigation2018

Self-adjuvanting nanoemulsion targeting dendritic cell receptor Clec9A enables antigen-specific immunotherapy.

Bijun Zeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.